Last reviewed · How we verify

NCT06761404: NOVUS

Non-invasive VNS in Stroke Recovery

Recruiting now NA Last updated 2 March 2026
What this trial tests

NA trial testing taVNS in Stroke in 60 participants. Currently enrolling.

Timeline
15 April 2025
Primary endpoint
31 December 2027
1 June 2028

Quick facts

Lead sponsorThe Methodist Hospital Research Institute
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date15 April 2025
Primary completion31 December 2027
Estimated completion1 June 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Methodist Hospital Research Institute

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate feasibility and effectiveness of non-invasive VNS to enhance stroke recovery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of taVNS

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other The Methodist Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing